Home LiteratureArticle Details
PMID: 42786675 Published · ppublish English Journal Article

Development and Characterization of a Fully Human Recombinant MPO-ANCA Monoclonal Antibody as Candidate Quality Control Material.

International journal of rheumatic diseases ·Vol. 29 ·No. 10 ·2026-10-00 ·页码 e70889

Guo M, Yuan Y, Zhang X, Liu Y

Abstract

MPO-ANCA detection suffers prominent inter-assay variability due to a shortage of standardized, sustainable quality control (QC) materials. Existing patient-pooled sera have limited supply, while chimeric monoclonal antibodies fail to fully mimic human autoantibodies. This study aimed to construct a fully human recombinant MPO-ANCA monoclonal antibody and systematically characterize its analytical performance as a candidate QC material for multi-platform MPO-ANCA immunoassay evaluation. A human anti-MPO scFv phage display library was constructed using peripheral blood mononuclear cells obtained from MPO-ANCA-positive patients. Following antigen-specific biopanning and screening, the candidate clone H042 was selected and converted into a full-length human IgG1 monoclonal antibody. We verified its structural integrity, antigen specificity, pANCA immunofluorescence pattern, quantitative linearity, thermal/freeze-thaw stability, and cross-kit performance across enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), multiplex flow immunoassay, and indirect immunofluorescence assay (IIFA) from multiple mainstream manufacturers. Purified H042 exhibited intact IgG structure, strong MPO binding affinity, and no cross-reactivity with PR3/GBM. It presented typical pANCA staining in IIFA and showed predictable quantitative response. H042 retained > 89% residual activity under accelerated thermal and repeated freeze-thaw stress. Notably, H042 yielded consistent qualitative positivity on all tested kits of four mainstream methodologies without false-negative signals, despite inter-platform signal intensity differences. The fully human monoclonal antibody H042 demonstrated favorable structural integrity, MPO specificity, and broad detectability across the evaluated commercial assay platforms. These characteristics support its potential as a scalable recombinant candidate QC material and an auxiliary tool for MPO-ANCA assay harmonization and laboratory quality assurance.

Keywords
ANCA‐associated vasculitis MPO‐ANCA fully human monoclonal antibody multi‐platform immunoassay standardization quality control material
MeSH 主题词
Humans Antibodies, Monoclonal/immunology Quality Control Recombinant Proteins/immunology Peroxidase/immunology Antibodies, Antineutrophil Cytoplasmic/immunology,blood Enzyme-Linked Immunosorbent Assay/standards Reproducibility of Results Predictive Value of Tests Antibody Specificity Protein Stability Fluorescent Antibody Technique, Indirect/standards Immunoglobulin G/immunology Biomarkers/blood
化学物质
Antibodies, Monoclonal Recombinant Proteins Peroxidase MPO protein, human Antibodies, Antineutrophil Cytoplasmic Immunoglobulin G Biomarkers
作者与单位
共 4 位作者,点击展开单位 / ORCID
Guo Meiyu ORCID
Department of Rheumatology, Beijing Hospital, National Center for Gerontology, National Clinical Research Center for Gerontology, The Key Laboratory of Geriatrics of NHC, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P.R. China.
Yuan Yeshuang ORCID
National Center for Clinical Laboratories, Beijing Hospital, National Center for Gerontology, National Clinical Research Center for Gerontology, The Key Laboratory of Geriatrics of NHC, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, P.R. China.
Zhang Xuan ORCID
Department of Rheumatology, Beijing Hospital, National Center for Gerontology, National Clinical Research Center for Gerontology, The Key Laboratory of Geriatrics of NHC, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P.R. China.
Liu Yudong ORCID
National Center for Clinical Laboratories, Beijing Hospital, National Center for Gerontology, National Clinical Research Center for Gerontology, The Key Laboratory of Geriatrics of NHC, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, P.R. China.
Article Info
Journal
International journal of rheumatic diseases
Abbr.
Int J Rheum Dis
ISSN
1756-185X
Published
2026-10-00
页码
e70889
Language
English
Country/Region
England
NLM ID
101474930
基金资助
National High Level Hospital Clinical Research Funding · BJ-2025-330
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]